A. Elias

1.1k total citations · 1 hit paper
7 papers, 788 citations indexed

About

A. Elias is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, A. Elias has authored 7 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in A. Elias's work include Sarcoma Diagnosis and Treatment (2 papers), Vascular Tumors and Angiosarcomas (1 paper) and Advanced Breast Cancer Therapies (1 paper). A. Elias is often cited by papers focused on Sarcoma Diagnosis and Treatment (2 papers), Vascular Tumors and Angiosarcomas (1 paper) and Advanced Breast Cancer Therapies (1 paper). A. Elias collaborates with scholars based in United States, Belgium and France. A. Elias's co-authors include Mehdi A. Fini, Richard J. Johnson, Richard M. Wright, Mohammed Milhem, George D. Demetri, Youn Choi Park, Margaret von Mehren, Robert G. Maki, Robin L. Jones and Martee L. Hensley and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

A. Elias

7 papers receiving 774 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial

2015 576 citations George D. Demetri, Margaret von Mehren et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by A. Elias

Since Specialization

Citations

This map shows the geographic impact of A. Elias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Elias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Elias more than expected).

Fields of papers citing papers by A. Elias

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Elias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Elias. The network helps show where A. Elias may publish in the future.

Co-authorship network of co-authors of A. Elias

This figure shows the co-authorship network connecting the top 25 collaborators of A. Elias. A scholar is included among the top collaborators of A. Elias based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Elias. A. Elias is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	LBA27 First-in-human results of STX-478, a mutant-selective PI3Ka inhibitor, in advanced solid tumor patients 2024 ·Annals of Oncology ·(unknown), (unknown), (unknown), Pamela N. Münster, (unknown), (unknown), (unknown), (unknown), (unknown), A. Elias, Aixa Soyano, (unknown), (unknown), Gennaro Daniele, (unknown), (unknown), Robert Wesolowski, C. Saura Manich, Chao Ma, Dejan Juric	5
2	Congenital Methemoglobinemia and Unstable Hemoglobin Variant in a Child With Cyanosis 2021 ·Cureus ·Mohammed Alsabri, Kusum Viswanathan, A. Elias, Mario Peichev	2
3	Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial breakdown → 2015 ·Journal of Clinical Oncology ·George D. Demetri, Margaret von Mehren, Robin L. Jones, Martee L. Hensley, Scott M. Schuetze, Arthur P. Staddon, Mohammed Milhem, A. Elias, Kristen N. Ganjoo, Hussein A. Tawbi, Brian Andrew Van Tine, Alexander I. Spira, Andrew Dean, Nushmia Z. Khokhar, Youn Choi Park, Roland E. Knoblauch, Trilok Parekh, Robert G. Maki, Shreyaskumar Patel	576
4	Contribution of uric acid to cancer risk, recurrence, and mortality 2012 ·SHILAP Revista de lepidopterología ·Mehdi A. Fini, A. Elias, Richard J. Johnson, Richard M. Wright	186
5	Trabectedin: Safety and Efficacy in the Treatment of Advanced Sarcoma 2011 ·Clinical Medicine Insights Oncology ·Csaba Gajdos, A. Elias	17
6	Early-stage BRCA2-linked breast cancer diagnosed in the first trimester of pregnancy associated with a hypercoagulable state. 2009 ·PubMed ·Jennifer R. Diamond, Christina Finlayson, Christiane D. Thienelt, Peter Kabos, (unknown), Linda A. Barbour, Catherine Klein, Rachel Rabinovitch, A. Elias, Virginia F. Borges	1
7	A woman with primary breast cancer and a solitary sternal metastasis. 2006 ·PubMed ·Alexander Menter, (unknown), Virginia F. Borges, Rachel Rabinovitch, Meenakshi Singh, William A. Robinson, Paul A. Seligman, Christina Finlayson, A. Elias	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact